Cargando…
TTK, CDC25A, and ESPL1 as Prognostic Biomarkers for Endometrial Cancer
OBJECTIVE: Endometrial cancer (EC) is one of the most common malignant gynaecological tumours worldwide. This study was aimed at identifying EC prognostic genes and investigating the molecular mechanisms of these genes in EC. METHODS: Two mRNA datasets of EC were downloaded from the Gene Expression...
Autores principales: | Yang, Qiannan, Yu, Bojun, Sun, Jing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7685798/ https://www.ncbi.nlm.nih.gov/pubmed/33282948 http://dx.doi.org/10.1155/2020/4625123 |
Ejemplares similares
-
ESPL1 Is a Novel Prognostic Biomarker Associated With the Malignant Features of Glioma
por: Liu, Zhendong, et al.
Publicado: (2021) -
ESPL1 is Elevated in Hepatocellular Carcinoma and Predicts Prognosis
por: Song, Rui, et al.
Publicado: (2022) -
TTK is a favorable prognostic biomarker for triple-negative breast cancer survival
por: Xu, Qianqian, et al.
Publicado: (2016) -
Integrated multi-omics analyses and functional validation reveal TTK as a novel EMT activator for endometrial cancer
por: Miao, Yu, et al.
Publicado: (2023) -
Pan-Cancer analysis and experimental validation identify the oncogenic nature of ESPL1: Potential therapeutic target in colorectal cancer
por: Zhong, Yuchen, et al.
Publicado: (2023)